Brief: NextBiomedical Secures FDA Breakthrough Device Designation
06/03/2025 14:03
March 6 (Reuters) - NextBioMedical Co Ltd 389650.KQ: NEXTBIOMEDICAL SECURES FDA BREAKTHROUGH DEVICE DESIGNATION FOR INNOVATIVE RESORBABLE MICROSPHERE 'NEXSPHERE-F™' Source text: ID:nPn8yttyVa Further company coverage: 389650.KQ (Reuters.Briefs@thomsonreuters.com)